Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SANTORO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.066
EU - Europa 1.755
AS - Asia 1.631
Continente sconosciuto - Info sul continente non disponibili 262
SA - Sud America 257
AF - Africa 46
OC - Oceania 5
Totale 8.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.987
SG - Singapore 685
RU - Federazione Russa 509
IT - Italia 482
CN - Cina 337
BR - Brasile 201
VN - Vietnam 145
DE - Germania 143
HK - Hong Kong 143
FI - Finlandia 140
PL - Polonia 102
GB - Regno Unito 76
BD - Bangladesh 71
FR - Francia 67
JP - Giappone 58
SE - Svezia 50
IN - India 46
CA - Canada 41
NL - Olanda 36
IE - Irlanda 31
AR - Argentina 23
RO - Romania 22
TR - Turchia 20
UA - Ucraina 19
ES - Italia 18
PK - Pakistan 18
KR - Corea 16
MX - Messico 16
BE - Belgio 15
IQ - Iraq 13
ZA - Sudafrica 12
AT - Austria 11
UZ - Uzbekistan 10
ID - Indonesia 9
IR - Iran 9
JM - Giamaica 8
MA - Marocco 7
CH - Svizzera 6
CL - Cile 6
CO - Colombia 6
CR - Costa Rica 6
EC - Ecuador 6
NP - Nepal 6
PY - Paraguay 6
JO - Giordania 5
MY - Malesia 5
RS - Serbia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
KE - Kenya 4
OM - Oman 4
SA - Arabia Saudita 4
TN - Tunisia 4
AU - Australia 3
EG - Egitto 3
GR - Grecia 3
KG - Kirghizistan 3
LY - Libia 3
PH - Filippine 3
DK - Danimarca 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
MG - Madagascar 1
ML - Mali 1
MM - Myanmar 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.761
Salva come PNG Salva come JPEG
Città #
Ashburn 529
Singapore 452
Fairfield 401
Chandler 272
San Jose 216
Woodbridge 180
Wilmington 162
Houston 149
Hong Kong 140
Seattle 137
Cambridge 136
Council Bluffs 125
Helsinki 99
Ann Arbor 89
Zgierz 84
Moscow 80
Beijing 76
Los Angeles 67
New York 67
Palermo 57
Dallas 56
Medford 54
Des Moines 48
Hanoi 43
Santa Clara 42
The Dalles 42
Tokyo 42
Lauterbourg 40
Altamura 39
Ho Chi Minh City 39
Boardman 37
Milan 36
Princeton 36
Rome 35
Lawrence 32
Dublin 31
Frankfurt am Main 26
Orem 25
San Diego 25
Buffalo 24
Venice 21
Atlanta 19
London 19
Chicago 18
Toronto 18
Hefei 16
Nanjing 16
Brooklyn 15
Brussels 15
Phoenix 15
São Paulo 15
Warsaw 14
Amsterdam 13
Chennai 13
Stockholm 13
Shanghai 12
Biandronno 10
Denver 10
Poplar 10
Tashkent 10
Bremen 9
Changsha 9
Columbus 9
Piscataway 9
Falkenstein 8
Guangzhou 8
Montreal 8
Munich 8
Ningbo 8
Jinan 7
Ludwigshafen am Rhein 7
Madrid 7
Mumbai 7
Nanchang 7
Naples 7
Nuremberg 7
San Paolo di Civitate 7
Tianjin 7
Bari 6
Boston 6
Johannesburg 6
Karachi 6
Lappeenranta 6
Lentini 6
Redondo Beach 6
Rio de Janeiro 6
San Francisco 6
San José 6
Washington 6
Amman 5
Bologna 5
Buenos Aires 5
Catania 5
Curitiba 5
Da Nang 5
Haiphong 5
Jakarta 5
Kumar 5
Mexico City 5
Naaldwijk 5
Totale 4.822
Salva come PNG Salva come JPEG
Nome #
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 407
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 345
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 309
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity 295
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 283
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 277
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. 268
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 241
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 230
Immunosenescence and lymphomagenesis 218
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 217
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 215
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 209
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study 201
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 192
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 191
Cardiovascular risk factor in MPN patients 189
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 181
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 175
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. 173
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 169
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? 168
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 168
Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms 164
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 155
A case of severe dermatitis in a patient with Polycythemia Vera during cytoreductive therapy 151
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review 147
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma 147
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 146
A Difficult Case of Ventriculitis in a 40-Year-Old Woman with Acute Myeloid Leukemia 142
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 142
Bone damage after chemotherapy for lymphoma: a real-world experience 139
High TIM-3 Expression May Contribute to the Functional Impairment of Bone Marrow and Circulating Gamma Delta T Lymphocytes during the Progression of Multiple Myeloma 139
Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant 131
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy 128
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy 126
Nutritional factors and survival in a cohort of patients with myelofibrosis 123
Familial essential thrombocythemia: 6 cases from a mono‐institutional series 122
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia 122
THE ANTINEOPLASTIC ROLE OF STAT5 INHIBITION IN BCRABL1-POSITIVE CELLS EXPOSED TO PIMOZIDE ALONE AND IN COMBINATION WITH DASATINIB AND PONATINIB 112
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps 108
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI) 89
P-386 A high risk of progression from smoldering to symptomatic multiple myeloma was predicted by bone marrow and circulating gamma delta T cells 84
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents 84
Totale 8.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022451 0 0 18 53 13 42 24 31 56 92 48 74
2022/2023755 68 147 23 93 67 125 33 60 106 4 20 9
2023/2024356 15 46 22 78 21 57 31 14 0 10 6 56
2024/2025826 11 41 33 70 53 29 56 87 66 91 130 159
2025/20263.340 245 149 154 283 436 481 467 320 266 252 123 164
2026/2027546 217 269 60 0 0 0 0 0 0 0 0 0
Totale 8.022